Altimmune Inc (ALT)

05:17 AM

Altimmune: Is There Still Hope For Pemvidutide? I Believe There Is (Upgrade) (NASDAQ:ALT) - Seeking Alpha

05:17 AM

04:37 AM

Altimmune (ALT) Stock Rises on FDA's Acceptance of Surrogate Endpoint - GuruFocus

04:37 AM

04:03 AM

ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

04:03 AM

04:00 AM

ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

04:00 AM

09:40 AM

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - PR Newswire

09:40 AM

12:34 PM

Will Altimmune Inc. price bounce be sustainable2025 Trade Ideas & High Conviction Investment Ideas - Newser

12:34 PM

Aug 26, 2025

Using Python tools to backtest Altimmune Inc. strategiesPortfolio Risk Summary & Growth Focused Entry Point Reports - Newser

Aug 26, 2025

Aug 26, 2025

Altimmune Inc. stock volume spike explainedTrend Reversal & Accurate Entry/Exit Alerts - Newser

Aug 26, 2025

Aug 26, 2025

Top chart patterns to watch in Altimmune Inc.2025 Momentum Check & Weekly Breakout Watchlists - Newser

Aug 26, 2025

Aug 26, 2025

Contact The Gross Law Firm by October 6, 2025 Deadline to Join Class Action Against Altimmune, Inc.(ALT) - PR Newswire

Aug 26, 2025

Aug 26, 2025

Bragar Eagel & Squire, P.C. Reminds Investors of Novo, - GlobeNewswire

Aug 26, 2025

Aug 26, 2025

Altimmune to Participate in Upcoming Investor Conferences - The Manila Times

Aug 26, 2025

Aug 26, 2025

Late-Stage Biotech Altimmune Announces Triple Conference Presence: Wells Fargo, HC Wainwright, Morgan Stanley - Stock Titan

Aug 26, 2025

Aug 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming DeadlinesALT - WV News

Aug 25, 2025

Aug 25, 2025

Levi & Korsinsky Moves to SueWallSt for Altimmune, Inc. Investors That Lost Money - Stockhouse

Aug 25, 2025

Aug 24, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. - GlobeNewswire

Aug 24, 2025

Aug 24, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Aug 24, 2025

Aug 24, 2025

Is Altimmune Inc. still worth holding after the dip2025 Growth vs Value & Low Risk Profit Maximizing Plans - Newser

Aug 24, 2025

Aug 24, 2025

Real time breakdown of Altimmune Inc. stock performanceJuly 2025 Recap & Free Technical Pattern Based Buy Signals - Newser

Aug 24, 2025

Aug 22, 2025

Class Action Filed Against Altimmune, Inc. (ALT)October 6, 2025 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire

Aug 22, 2025

Aug 21, 2025

Altimmune, Inc. Sued for Securities Law Violations - GlobeNewswire

Aug 21, 2025

Aug 21, 2025

Faruqi & Faruqi investigates potential claims against Altimmune, Inc. - AInvest

Aug 21, 2025

Aug 20, 2025

ALT STOCK: Robbins LLP Reminds ALT Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Altimmune, Inc. - PR Newswire

Aug 20, 2025

Aug 20, 2025

Will Altimmune Inc. continue its uptrend2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - Newser

Aug 20, 2025

Aug 20, 2025

Altimmune, Inc. (NASDAQ:ALT) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

Aug 20, 2025

Aug 19, 2025

Altimmune wins FDA fast track status for alcohol use disorder therapy - MSN

Aug 19, 2025

Aug 19, 2025

Will Altimmune Inc. stock recover after recent dropQuarterly Market Summary & Precise Trade Entry Recommendations - Newser

Aug 19, 2025

Aug 19, 2025

Altimmune Inc (ALT) Stock: A Comprehensive 52-Week Review - investchronicle.com

Aug 19, 2025

Aug 19, 2025

ALT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Altimmune, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Aug 19, 2025

Aug 19, 2025

Altimmune (ALT) Gains FDA Fast Track for Alcohol Use Disorder Treatment - GuruFocus

Aug 19, 2025

Aug 19, 2025

Shareholders that lost money on Altimmune, Inc.(ALT) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - MarketScreener

Aug 19, 2025

Aug 19, 2025

Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD) - The Manila Times

Aug 19, 2025

Aug 19, 2025

Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD) | ALT Stock News - GuruFocus

Aug 19, 2025

Aug 19, 2025

Altimmune's Pemvidutide Receives FDA Fast Track Designation for Alcohol Use Disorder Treatment - Quiver Quantitative

Aug 19, 2025

Aug 19, 2025

Trend analysis for Altimmune Inc. this weekMarket Activity Recap & Scalable Portfolio Growth Ideas - Newser

Aug 19, 2025

Aug 18, 2025

Lost Money on Altimmune, Inc. (ALT)? Join Class Action Before October 6, 2025Contact Levi & Korsinsky - ACCESS Newswire

Aug 18, 2025

Aug 18, 2025

Class Action Filed Against Altimmune, Inc. – Investors with Losses Encouraged to Contact Johnson Fistel - GlobeNewswire

Aug 18, 2025

Aug 18, 2025

Rosen Law Firm Urges Altimmune, Inc. (NASDAQ: ALT) Stockholders to Contact the Firm for Information About Their Rights - PR Newswire

Aug 18, 2025

Aug 18, 2025

ALT LAWSUIT ALERT: The Gross Law Firm Notifies Altimmune, - GlobeNewswire

Aug 18, 2025

Aug 18, 2025

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 6, 2025 in Altimmune, Inc. LawsuitALT - PR Newswire

Aug 18, 2025

Aug 18, 2025

Altimmune Inc. stock trend outlook and recovery pathWeekly Trend Report & Low Drawdown Investment Strategies - Newser

Aug 18, 2025